Yole Développement Announces Foundation of BLUMORPHO
News Feb 17, 2015
Yole Développement (Yole) announces the founding of daughter company, BLUMORPHO SAS. BLUMORPHO’s mission is to create value from all forms of innovation.
BLUMORPHO is developing businesses for its customers by building a dynamic marketplace and is active all along the innovation chain, from research to market.
The spin-off will undertake Yole Finance Innovation activities dedicated to supporting technology exploitation, young companies’ maturation and intellectual property portfolio optimization.
“BLUMORPHO is operating an innovative business model in marketing a portfolio of attractive technologies to serve industrial needs and demand”, explains Géraldine Andrieux Gustin, CEO & Co-founder of BLUMORPHO. “We facilitate access to technologies and innovations with added value for industrial companies. Based on Yole’s expertise, and our hands-on experience, we identify bankable challenges in different industries and we match them with relevant solutions and technologies to address those needs. As a trusted third party active throughout the ecosystem, BLUMORPHO supports successful innovation processes”, she adds.
The concept of this new business model has been tested and validated in the course of COWIN, which was initiated and led by Géraldine as Yole Finance’s Senior Partner. Sponsored by the European Commission, COWIN was dedicated to facilitating the commercial exploitation of results from European research projects on smart systems. From 2010 to 2014, COWIN generated about 25 million Euros’ worth of investment opportunities in technology exploitation.
“The launch of BLUMORPHO is a natural continuation of COWIN. BLUMORPHO will contribute to maintaining COWIN’s momentum by working in close collaboration with European technology owners engaged in driving their innovations to market,” highlighted BLUMORPHO’s CEO & Co-founder.
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE
Making Drug Microparticles a Thousand Times FasterNews
Pharmaceuticals owe their effects mostly to their chemical composition, but the packaging of these drugs into specific physical formulations also need to be done to exact specifications. Engineers have now developed a microfluidic system where more than ten thousand devices run in parallel, all on a silicon-and-glass chip that can fit into a shirt pocket.READ MORE